{"filing":{"accession_number":"0001493152-26-041901","cik":"0001725430","ticker":"INBS","company_name":"INTELLIGENT BIO SOLUTIONS INC.","form":"8-K","filing_date":"2026-09-09","report_date":"2026-09-09","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226041901/form8-k.htm"},"events":[{"id":32245,"run_id":29625,"accession_number":"0001493152-26-041901","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses submission of a 510(k) premarket notification to the FDA for the Intelligent Fingerprinting Drug Screening System seeking regulatory clearance for codeine detection. This is a material regulatory milestone for a medical device company, representing a key step toward U.S. market entry in a multi-billion-dollar drug screening market. While not fitting a specific named event type, this is clearly an operational/strategic business event—a regulatory submission milestone—that would affect a reasonable investor's assessment of the company's commercialization progress and market opportunity.","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":35372,"accession_number":"0001493152-26-041901","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses submission of a 510(k) premarket notification to the FDA for the Intelligent Fingerprinting Drug Screening System seeking regulatory clearance for codeine detection. This is a material regulatory milestone for a medical device company, representing a key step toward U.S. market entry in a multi-billion-dollar drug screening market. While not fitting a specific named event type, this is clearly an operational/strategic business event—a regulatory submission milestone—that would affect a reasonable investor's assessment of the company's commercialization progress and market opportunity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T12:51:38.059992+00:00","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-09-09"}]}